Glutarate—CoA ligase
Glutarate—CoA ligase (also known as glutaryl-CoA synthetase, GCS, or glutaryl-Coenzyme A synthetase) is an enzyme that plays a crucial role in the metabolism of lysine, tryptophan, and hydroxylysine in mammals, including humans. It catalyzes the ATP-dependent ligation of Coenzyme A (CoA) to glutarate, forming glutaryl-CoA, a key intermediate in the degradation pathway of these amino acids. This reaction is essential for the conversion of certain amino acids into energy during metabolic processes.
Function
Glutarate—CoA ligase is involved in the metabolism of lysine, tryptophan, and hydroxylysine, which are important amino acids used by the body to produce proteins, hormones, and other vital molecules. The enzyme facilitates the fifth step in the degradation pathway of these amino acids, converting glutarate into glutaryl-CoA. This conversion is critical for the proper processing and elimination of these amino acids, preventing the accumulation of potentially harmful substances in the body.
Genetics
The gene responsible for encoding glutaryl-CoA synthetase is located on human chromosome 19. Mutations in this gene can lead to a rare metabolic disorder known as glutaric aciduria type 1 (GA1). GA1 is characterized by an accumulation of glutaric acid and its derivatives in the body, which can lead to neurological damage and other severe complications if not diagnosed and managed promptly.
Clinical Significance
Glutaric aciduria type 1 (GA1) is the most significant clinical condition associated with deficiencies in glutaryl-CoA synthetase activity. Early diagnosis and management of GA1 are crucial to prevent the development of severe neurological symptoms, including dystonia, choreoathetosis, and seizures. Dietary management and carnitine supplementation are among the treatments used to manage GA1, aiming to limit the accumulation of toxic metabolites in the body.
Biochemical Pathway
The biochemical pathway involving glutaryl-CoA synthetase is a part of the broader catabolic pathways of lysine, tryptophan, and hydroxylysine. After the initial steps of amino acid degradation, glutarate is produced as an intermediate. Glutarate—CoA ligase then catalyzes the formation of glutaryl-CoA, which is subsequently processed through several more steps before being fully degraded into acetyl-CoA or other metabolites that can enter the citric acid cycle for energy production.
See Also
References
This article is a biochemistry stub. You can help WikiMD by expanding it!
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD